Adma Biologics (ADMA) Other Gross PP&E Adjustments: 2011-2025
Historic Other Gross PP&E Adjustments for Adma Biologics (ADMA) over the last 9 years, with Sep 2025 value amounting to -$19.9 million.
- Adma Biologics' Other Gross PP&E Adjustments fell 129.57% to -$19.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $195.9 million, marking a year-over-year decrease of 26.72%. This contributed to the annual value of $68.1 million for FY2024, which is 4.74% up from last year.
- As of Q3 2025, Adma Biologics' Other Gross PP&E Adjustments stood at -$19.9 million, which was down 126.72% from $74.7 million recorded in Q2 2025.
- In the past 5 years, Adma Biologics' Other Gross PP&E Adjustments ranged from a high of $74.7 million in Q2 2025 and a low of -$19.9 million during Q3 2025.
- Over the past 3 years, Adma Biologics' median Other Gross PP&E Adjustments value was $67.3 million (recorded in 2024), while the average stood at $59.6 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first climbed by 22.76% in 2022, then crashed by 129.57% in 2025.
- Over the past 5 years, Adma Biologics' Other Gross PP&E Adjustments (Quarterly) stood at $52.2 million in 2021, then increased by 22.76% to $64.1 million in 2022, then increased by 1.40% to $65.0 million in 2023, then grew by 4.74% to $68.1 million in 2024, then crashed by 129.57% to -$19.9 million in 2025.
- Its Other Gross PP&E Adjustments was -$19.9 million in Q3 2025, compared to $74.7 million in Q2 2025 and $73.1 million in Q1 2025.